Evidence map›Paper›PMID 32167087›Full record

ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2019

Preventing transmission of bloodborne viruses from infected healthcare workers to patients: Summary of a new Canadian Guideline.

T Ogunremi, K Defalco, B L Johnston, M Vearncombe, A M Joffe, B Cleghorn, M Cividino, D K Wong, T Mazzulli, J Wong and 5 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 1 country.

T OgunremiCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
K DefalcoCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
B L JohnstonDalhousie University, Halifax, NS.
M VearncombeUniversity of Toronto, Toronto, ON.
A M JoffeUniversity of Alberta, Edmonton, AB.
B CleghornDalhousie University, Halifax, NS.
M CividinoSt. Joseph's Healthcare Hamilton, Hamilton, ON.
D K WongUniversity of Toronto, Toronto, ON.
T MazzulliUniversity of Toronto, Toronto, ON.
J WongBC Centre for Disease Control, Vancouver, BC.
M A IsingerClinical Ethicist, Ottawa, ON.
Y RobertCollège des médecins du Québec, Montréal, QC.
I BoucoiranCentre hospitalier universitaire Sainte-Justine, Montréal, QC.
K DunnCentre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
B HenryUniversity of British Columbia, Vancouver, BC.
Public Health Agency of Canada · CADalhousie University · CAUniversity of Toronto · CAAlberta Health Services · CACentre Hospitalier Universitaire Sainte-Justine · CAEthica (Canada) · CAMinistry of Health · CAMount Sinai Hospital · CASt. Joseph’s Healthcare Hamilton · CAUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough it is well documented that bloodborne viruses (BBVs), including human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV) have been transmitted from patients to healthcare workers (HCWs), there has also been reported transmission from HCWs to patients during the provision of health care. With remarkable progress in infection prevention, diagnosis tools, treatment regimens and major improvements in guideline development methodology, there was a need to develop an evidence-based guideline to replace the 1998 Canadian consensus document for managing HCWs infected with BBVs. PURPOSE: This article summarizes the Canadian

methodsA Guideline Development Task Group was established and key questions developed to inform the guideline content. Systematic reviews were conducted to evaluate the risk of HCW-to-patient transmission of HIV, HCV and HBV. Environmental scans were used to provide information on Expert Review Panels, disclosure of a HCW's serologic status and lookback investigations. Federal, provincial and territorial partners and key stakeholder organizations were consulted on the Guideline.

resultsThe risk of HCW-to-patient BBV transmission was found to be negligible, except during exposure-prone procedures, where there is a risk that injury to the HCW may result in exposure of a patient's open tissues to the HCW's blood. Risk of ensuing transmission and the rate of transmission varied by BBV, and were lowest with HIV and highest with HBV. The Guideline provides key content, including recommendations regarding criteria to determine if a procedure is an exposure-prone procedure, management of HCWs infected with a BBV, including considerations for the HCW's fitness for practice, Expert Review Panels, HCW disclosure obligations and right to privacy and lookback investigations.

conclusionThis new Guideline provides a pan-Canadian approach for managing HCWs infected with a BBV, with recommendations related to preventing HCW-to-patient transmission of BBVs during the provision of care.

Indexed as

bloodborne pathogensbloodborne virusesCanadaexposure-prone procedureguidelinehealthcare workershepatitis Bhepatitis CHIVrecommendationstransmission

Identifiers

PMID32167087
PMCPMC7041653
OpenAlexW2996607321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.